| Combined oral contraceptives in women with systemic lupus erythematosus M Petri, MY Kim, KC Kalunian, J Grossman, BH Hahn, LR Sammaritano, ... New England Journal of Medicine 353 (24), 2550-2558, 2005 | 1217 | 2005 |
| Trial of anifrolumab in active systemic lupus erythematosus EF Morand, R Furie, Y Tanaka, IN Bruce, AD Askanase, C Richez, ... New England Journal of Medicine 382 (3), 211-221, 2020 | 940 | 2020 |
| The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial JP Buyon, MA Petri, MY Kim, KC Kalunian, J Grossman, BH Hahn, ... Annals of internal medicine 142 (12_Part_1), 953-962, 2005 | 740 | 2005 |
| The frequency and outcome of lupus nephritis: results from an international inception cohort study JG Hanly, AG O’Keeffe, L Su, MB Urowitz, J Romero-Diaz, C Gordon, ... Rheumatology 55 (2), 252-262, 2016 | 560 | 2016 |
| A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ... Annals of the rheumatic diseases 76 (3), 554-561, 2017 | 369 | 2017 |
| Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE MA Dooley, F Houssiau, C Aranow, DP D’Cruz, A Askanase, DA Roth, ... Lupus 22 (1), 63-72, 2013 | 316 | 2013 |
| Cancer risk in systemic lupus: an updated international multi-centre cohort study S Bernatsky, R Ramsey-Goldman, J Labrecque, L Joseph, JF Boivin, ... Journal of autoimmunity 42, 130-135, 2013 | 294 | 2013 |
| Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to … PM Izmirly, MY Kim, C Llanos, PU Le, MM Guerra, AD Askanase, ... Annals of the rheumatic diseases 69 (10), 1827-1830, 2010 | 290 | 2010 |
| Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-α by macrophages ME Miranda-Carus, AD Askanase, RM Clancy, F Di Donato, TM Chou, ... The Journal of Immunology 165 (9), 5345-5351, 2000 | 216 | 2000 |
| Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies AD Askanase, DM Friedman, J Copel, MR Dische, A Dubin, TJ Starc, ... Lupus 11 (3), 145-151, 2002 | 212 | 2002 |
| The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan lupus surveillance program PM Izmirly, I Wan, S Sahl, JP Buyon, HM Belmont, JE Salmon, ... Arthritis & rheumatology 69 (10), 2006-2017, 2017 | 192 | 2017 |
| Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block RM Clancy, RP Kapur, Y Molad, AD Askanase, JP Buyon Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 185 | 2004 |
| Long‐term followup of children with neonatal lupus and their unaffected siblings V Martin, LA Lee, AD Askanase, M Katholi, JP Buyon Arthritis & Rheumatism 46 (9), 2377-2383, 2002 | 166 | 2002 |
| 2021 DORIS definition of remission in SLE: final recommendations from an international task force RF van Vollenhoven, G Bertsias, A Doria, D Isenberg, E Morand, MA Petri, ... Lupus Science & Medicine 8 (1), e000538, 2021 | 147 | 2021 |
| Phase II randomized trial of rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis Y Atisha‐Fregoso, S Malkiel, KM Harris, M Byron, L Ding, S Kanaparthi, ... Arthritis & rheumatology 73 (1), 121-131, 2021 | 147 | 2021 |
| Lymphoma risk in systemic lupus: effects of disease activity versus treatment S Bernatsky, R Ramsey-Goldman, L Joseph, JF Boivin, KH Costenbader, ... Annals of the rheumatic diseases 73 (1), 138-142, 2014 | 147 | 2014 |
| Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block PM Izmirly, C Llanos, LA Lee, A Askanase, MY Kim, JP Buyon Arthritis & Rheumatism 62 (4), 1153-1157, 2010 | 137 | 2010 |
| Mood disorders in systemic lupus erythematosus: results from an international inception cohort study JG Hanly, L Su, MB Urowitz, J Romero‐Diaz, C Gordon, SC Bae, ... Arthritis & rheumatology 67 (7), 1837-1847, 2015 | 125 | 2015 |
| Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block RM Clancy, AD Askanase, RP Kapur, E Chiopelas, N Azar, ... The Journal of Immunology 169 (4), 2156-2163, 2002 | 111 | 2002 |
| Safety and efficacy of belimumab to treat systemic lupus erythematosus in academic clinical practices JS Hui-Yuen, A Reddy, J Taylor, X Li, AH Eichenfield, LM Bermudez, ... The Journal of rheumatology 42 (12), 2288-2295, 2015 | 106 | 2015 |
